Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (311K) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Svinarchuk, F.
Right arrow Articles by Chern D$[corrected to Cherny, D]
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svinarchuk, F.
Right arrow Articles by Chern D$[corrected to Cherny, D]
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 3459-3464

Recruitment of transcription factors to the target site by triplex-forming oligonucleotides

Recruitment of transcription factors to the target site by triplex-forming oligonucleotides Fedor Svinarchuk1,2,*, Irina Nagibneva3, Dmitry Cherny4,5, Slimane Ait-Si-Ali3, Linda L. Pritchard3, Philippe Robin3, Claude Malvy1 and Annick Harel-Bellan3

1Laboratoire de Biochimie-Enzymologie, CNRS URA 147, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France, 2Department of Biochemistry, Novosibirsk Institute of Bioorganic Chemistry, 8 Prospect Lavrenteva, Novosibirsk 630090, Russia, 3Laboratoire `Oncogénése, Différenciation et Transduction du Signal', CNRS UPR 9079, CNRS, Institut Fédératif sur le Cancer (IFC-01), 7 rue Guy Moquet, 94801 Villejuif Cedex, France, 4Laboratoire de Microscopie cellulaire et moléculaire, CNRS URA 147, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France and 5Institute of Molecular Genetics, RAS, Kurchatov's Square, Moscow 123182, Russia

Received May 19, 1997; Revised and Accepted July 18, 1997

ABSTRACT

Triplex-forming oligonucleotides (TFOs) are generally designed to inhibit transcription or DNA replication but can be used for more diverse purposes. Here we have designed a hairpin-TFO able to recruit transcription factors to a target DNA. The designed oligonucleotide contains a triplex-forming sequence, linked through a nucleotide loop to a double-stranded hairpin including the SRE enhancer of the c-fos gene promoter. We show here that this oligonucleotide can specifically recognise its DNA target at physiological salt and pH conditions. The stability of the triplex formed under these conditions is very high: >90% of the triplex remains intact after 24 h of incubation. Bound to the double-stranded target DNA, the oligonucleotide retains its ability to interact specifically with transcription factors, recruiting them to the proximity of the target DNA. Our results suggest that this type of oligonucleotide may prove useful in the design of new tools for artificial modulation of gene expression.

INTRODUCTION

Triplex-forming oligonucleotides (TFOs) represent a new approach to artificially regulate gene expression through direct interaction with DNA. Indeed, TFOs targeted against gene promoters can modulate transcription of the targeted gene (1 ). Two types of TFOs have been described. Pyrimidine oligonucleotides are composed of thymidines and cytosines and bind in parallel orientation to runs of purine acceptors of a duplex DNA through Hoogsteen base pairing. In the second type of TFOs, the oligonucleotides are composed of guanosines and adenosines or thymidines, and bind in an antiparallel orientation to the purine acceptor strand via reverse Hoogsteen base pairing (reviewed in 2 ,3 ).

TFOs can bind specifically to their target sequences even if these targets are present as a single copy in a DNA molecule as long as a yeast chromosome (4 ), a human chromosome (5 ) or even in the whole human genome (6 ), which makes them very attractive compounds for gene-targeted therapy. They have been designed mainly to bind in the vicinity of transcription factor target sites and to act as competitors for these proteins. Alternatively, they can introduce a lesion in a sequence-specific manner which will prevent DNA/RNA polymerase movement through the target template. In all these cases, TFOs play a negative role, inhibiting a biochemical process by preventing normal interactions between the targeted DNA and protein factors (reviewed in 7 ). However, TFOs potentially could be used for more diverse purposes. For example, TFO-based DNA bending ligands have been designed (8 ). In the present work we have designed an oligonucleotide able to recruit transcription factors to the target DNA sequence.

These molecules (hairpin-TFOs) are bi-functional oligonucleotides, which contain a hairpin able to bind transcription factors, and a sequence forming a triple helix on a target DNA (see Fig. 1 A). The specific oligonucleotide that we have used in this study contains a homopurine triplex-forming sequence which is targeted to the vpx gene of HIV-2 (and SIV) and forms highly stable triple helices (9 ). This TFO portion is linked, through a nucleotide loop, to a double-stranded hairpin including transcription factor binding sites from the SRE enhancer of the c-fos gene promoter. The SRE enhancer (10 ) is present in the upstream regulatory sequence of a number of immediate early genes (11 ,12 ). The SRE is constitutively occupied by a complex of two proteins, p67SRF (13 ) and p62TCF (14 ). P67SRF recognizes a CArG box in the SRE (15 ). P62TCF, either the ELK-1 or the SAP-1 protein, does not bind autonomously to the element but requires the presence of SRF in order to efficiently contact DNA (16 ,17 ), thus forming a ternary complex.


Figure 1.Model of the hairpin-TFO (A) and sequences of the oligonucleotides used in this study (B). The single-stranded part of the oligonucleotides includes the triplex-forming sequence (TFO) (in bold) and three T, which were chosen as a flexible spacer to connect the TFO to the hairpin structure. The hairpin structure contains binding sites for SRF and ELK. mSRE-TFO contains a mutated SRE site (in small italics); mTFO-SRE contains a mutated TFO sequence (in small italics).

Here we show that the bi-functional `SRE-TFO' can specifically recognise its DNA target under physiological salt and pH conditions. The stability of the triplex under these conditions is very high: >90% of the triplex remains intact after 24 h incubation. Bound to the double-stranded target DNA, the oligonucleotide retains its ability to interact specifically with transcription factors, recruiting them to the proximity of the target DNA. Our results suggest that this type of oligonucleotide may prove useful in the design of new tools for artificial modulation of gene expression.

MATERIALS AND METHODS

Plasmids

The plasmid pVPX1 containing the polypurine stretch of the SIV vpx gene was constructed by inserting the oligonucleotides 5"-CTAGACCTGGAGGGGGAGGAGGAGGAGGTCCG-3" and 5"-GATCCGGACCTCCTCCTCCTCCCCCTCCAGGT-3" into the XbaI-BamHI sites of the vector pBluescript II. All plasmids were purified on Qiagen columns, following the manufacturer's recommendations.

Oligonucleotides

Oligodeoxynucleotides were synthesised using an Applied Biosystems 391A DNA synthesiser and purified by electrophoresis on denaturing 20% polyacrylamide gels. The different oligonucleotides used are presented in Figure 1 B.

DMS footprinting

To prepare a DNA fragment for modification by DMS the pVPX1 plasmid was cut with the ClaI restriction enzyme, 3" labelled with the Klenow fragment of DNA polymerase I, and digested with the XhoI restriction enzyme. A larger labelled fragment (1.0 pmol) was dissolved in a 20 [mu]l volume containing 50 mM MOPS, pH 7.2, 10 mM MgAc2 and 50 mM NaAc. After addition of the TFO (10 pmol), the mixture was incubated at 37oC for 2 h. Then 2 [mu]l of 5% DMS was added and the methylation reaction was performed for 2 min at 25oC. The reaction was stopped by the addition of 5 [mu]l of a solution containing 10% mercaptoethanol, 1 mM EDTA and 0.1 M NaAc. After two precipitations in ethanol, the samples were treated with 50 [mu]l of 10% piperidine at 95oC for 15 min, and the cleavage products were separated on a denaturing 6% polyacrylamide gel.

Electrophoretic mobility shift assay (EMSA)

SRF and ELK-1 were produced by in vitro translation as described (18 ). In some experiments, SRF was produced in bacteria as GST-SRF and prepared as described (19 ).

The SRE, SRE-TFO, SRE-mTFO and mSRE-TFO oligonucleotides, described in Figure 1 , were 5" end labelled (1000 Ci/mmol) using T4 polynucleotide kinase and [[gamma]-32P]ATP, purified on denaturing acrylamide gels, and annealed. Interaction between hairpin-TFOs and transcription factors was assayed in the following manner: 2 [mu]l in vitro translated SRF or ELK proteins were preincubated in 20 [mu]l of EMSA buffer (188 mM NaCl, 50 mM HEPES pH 7.9, 2.5 mM EDTA, 2.5 mM DTT, 12% glycerol) with 1-2 [mu]g salmon sperm, together with an excess of unlabeled competitor oligonucleotide (where indicated). After 15 min on ice, 32P-labelled oligonucleotide probes (0.5 pmol) were added, and the incubation was allowed to continue for an additional 10 min at room temperature. Samples were electrophoresed in 5% polyacrylamide gel in 0.5*TBE at 10oC in a Hoefer Mighty Small II apparatus. Gels were dried and analysed using a Phosphoimager (BAS 1000, Fuji), and by conventional autoradiography.

Formation of the multimolecular complex including the target DNA, hairpin-TFO, and the transcription factors was assayed in the following manner: 1 pmol of double-stranded DNA was first incubated with 1 pmol of the third-strand oligonucleotide in a 10 [mu]l solution containing 10 mM MgAc2, 20 mM TrisAc, pH 7.5, and 50 mM NaAc for 1 h to form the triple helix. Two [mu]l of this mixture were used for incubation with the transcription factors in 20 [mu]l of 0.5*TBE supplemented with 2 mM MgAc2 and 1 [mu]g of salmon sperm DNA, as described above. Samples were electrophoresed at 10oC in 0.5*TBE supplemented with 2 mM MgAc2.

Electron microscopy

After formation of the triple helix between pVPX1 linearized by KpnI and the SRE-TFO as described (20 ), a 5 [mu]l aliquot containing 1-3 mg/ml DNA (in 10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, pH 7.4) was applied to a carbon film glow- discharged in the presence of pentylamine vapours using the method of (21 ). Samples were stained with 0.5-1% aqueous uranyl acetate for 10 s and blotted with filter paper; they were then observed with a Zeiss/LEO CEM-902 electron microscope in the annular dark-field mode as described by (22 ,23 ). Image recording and measurements of DNA molecules were performed with the built-in Kontron image analyser system and software.

RESULTS AND DISCUSSION

Hairpin-TFOs form stable triplexes with target DNA


Figure 2.Binding of the hairpin-TFO to the target sequence. (A) Autoradiogram of a 6% polyacrylamide sequencing gel showing the results of a DMS footprinting experiment carried out with SRE-TFO: lane 1, SRE-TFO; lane 2, control oligonucleotide 5'-GGATTAGTATGATGGCCAGG-3'.

A model hairpin triplex-forming oligonucleotide (SRE-TFO) was designed as described in Figure 1 A. The TFO part binds to the polypurine/polypyrimidine tract of the vpx gene of Simian immunodeficiency virus (SIV) in a highly stable manner (9 ,24 ). The TFO part is connected, via a linker consisting of three thymines, to a hairpin containing the sequence of the Serum Responsive Element (SRE), an enhancer from the c-fos gene promoter (Fig. 1 B). To check the specificity of the interaction between the hairpin-TFO and the target DNA or transcription factors, we have used hairpin-TFOs with a mutated TFO sequence (SRE-mTFO) or a mutated hairpin sequence (mSRE-TFO) (Fig. 1 ).

Formation of triplexes between the target DNA and the hairpin-TFOs has been demonstrated by three methods. First, triplex formation with the pVPX1 plasmid containing the target sequence, in a buffer containing 50 mM Na+, was monitored by a DMS footprinting assay (Fig. 2 ). DMS modifies the N7 position of guanines, leading to phosphate backbone chain cleavage after treatment with piperidine. This reaction does not occur with the purines of the double-stranded DNA within a purine-purine-pyrimidine triplex, due to the formation of Hoogsteen base pairing (25 ). Figure 2 shows that the guanines located within the target sequences of the SRE-TFO are less sensitive to DMS than are those external to the target sequence, indicating that a triplex is formed with the oligonucleotide under these experimental conditions. The pattern of the protection by SRE-TFO was similar to that observed with the TFO part alone (data not shown).


Figure 3.Visualisation of the triplex by electron microscopy (EM). A linearised plasmid which contains the target sequence was incubated with the SRE-TFO and processed for EM. The sites of triplex formation can be observed as short sticks, oriented perpendicularly to the axis of the double-stranded DNA (indicated by arrows).In parallel, electron microscopy was used to detect the triplex formed by the SRE-TFO on its target. The stem part of the oligonucleotide can easily be seen as a short stick, usually oriented perpendicularly to the axis of the double-stranded DNA on the electron micrograph (Fig. 3 ). The estimated length of the protruding DNA was 29 +- 4 bp which is in good agreement with the length of the hairpin. The position of the hairpin (85 +- 6 bp from the last nucleotide in the 3" end of the target sequence) coincides with the position of the target sequence (86 bp). When the experiments were performed in the presence of SRE-mTFO, no triplexes were detected on the electron micrographs (data not shown). The high selectivity of this hairpin-TFO was also demonstrated by the fact that, at all levels of target occupancy studied (up to 80%), no non-specific interaction was observed over the entire plasmid sequence.

Finally, the formation of triplexes between the hairpin-TFOs and whole plasmids was checked in co-migration experiments (data not shown). Only the oligonucleotides designed to form a triplex with the vpx sequence (SRE-TFO and mSRE-TFO) migrated with the plasmid pVPX1. No oligonucleotide migrated with the control plasmid pBlueskript SK (data not shown). The stability of the triplex was assayed by cold chase experiments. After triplex formation, using an equimolar mixture of the plasmid and the 5" 32P-labelled SRE-TFO, a 500-fold molar excess of the oligonucleotide 5"-GGAGGAGGAGGAGGGGGAGG-3", designed to form a triplex with the same target (26 ) was added to the mixture. After incubation in 10 [mu]l of a buffered solution (containing 10 mM MgCl2, 150 mM KAc and 20 mM TrisAc, pH 7.5) during various periods of time at 37oC, the amount of radioactivity which remains bound to the pVPX1 was evaluated by a co-migration assay. Under the conditions of this experiment >90% of the 5' 32P-labelled oligonucleotide remains bound to the plasmid after 24 h of incubation (Fig. 4 ).


Figure 4.Determination of the stability of the triplex. A triplex was formed between plasmid pVPX1 containing the target sequence and a radiolabeled SRE-TFO. After different times of incubation with an excess of non-labelled competitor TFO, the mixture was analysed by co-migration assays (29). (A) Autoradiogram of a dried agarose gel. Lanes from 1 to 6 correspond to 24, 3, 1, 0.5, 0.25, and 0 h incubation, respectively. Lane 7: sample without competitor oligonucleotide. (B) The same gel as (A) after staining with ethidium bromide.


Figure 5. Analysis of the interaction between the hairpin-TFO and SRF or ELK-1. SRF and ELK-1 were transcribed and translated in vitro. (A) The interaction was analysed by EMSA using radiolabelled SRE-TFO (lanes 1-3), SRE-mTFO (lanes 4, 5), mSRE-TFO (lanes 6, 7), and SRE (lanes 8, 9) as probes. In the control lanes mock-translated samples were used. (B) ELK-1 forms a ternary complex with SRF and the hairpin-TFO. Equivalent amounts of SRF and ELK-1 were incubated with the SRE-TFO (lanes 1-4), the SRE-mTFO (lanes 5-7), and the SRE (lanes 8-10) as probes. In this experiment the radiolabelled probe is the target DNA to which unlabelled SRE-TFO is complexed. To avoid absorption of transcription factors by non-labelled free SRE-TFO triplex formation was performed at equimolar concentration of the target DNA and SRE-TFO. Under these conditions, triplex is formed with only 15% of the target DNA, and can easily be seen on a less exposed gel (data not shown). Because our goal was to see the multimolecular complex formation, the part of the gel presenting duplex DNA and triplex is overexposed; consequently the signal from target DNA partially mask the retarded band for triplex.

SRF and ELK-1 bind to the hairpin-TFO

The interaction between the transcription factors and the hairpin-TFO was analysed by EMSA. The SRE-TFO and SRE-mTFO hairpins both contain a CArG box, specifically recognized by SRF. Both oligonucleotides bound SRF as efficiently as a classic double-stranded probe used as a control (Fig. 5 A); the ratio of the retarded band to the total radiolabelled oligonucleotide was the same for all three probes (SRE, SRE-TFO and SRE-mTFO). The SRE sequence of the c-fos promoter contains, in addition to the CArG box, an Ets box (Fig. 1 ). The Ets box is recognised by ELK-1 but only when the adjacent CArG box is occupied by SRF (16 ,17 ), thus forming a ternary complex which can be observed in EMSA as a supershifted band as compared with that of the SRE/SRF complex (18 ). As seen in Figure 5 B, lanes 4 and 7, SRE-TFO and SRE-mTFO have the ability to bind SRF and ELK-1 simultaneously. The formation of the ternary complex was specific, since no retarded bands were detected when similar experiments were performed with mSRE-TFO, in which the CArG and Ets boxes are mutated (Fig. 5 A, lane 5). Thus, the SRE-TFO is able to specifically interact with the transcription factors.


Figure 6. Analysis of the target DNA/(SRE-TFO)/SRF multimolecular complex formation. (A) In vitro translated SRF was incubated with a mixture containing an [[alpha]-32P]-labelled fragment from the pVPX1 (D*) and the SRE-mTFO (lane 1), the mSRE-TFO (lane 2), or the SRE-TFO (lane 3). In lanes 4-9 SRF was omitted. (B) Competition experiments. The multimolecular complex was formed as in (A), but the indicated excesses of unlabelled SRE probe were added (lanes 1-3). In lanes 9 and 10 (A) or 4 and 5 (B), D* was replaced by radiolabelled SRE probe. The band marked by an `X' most likely represents a dimer of the hairpin-TFO, bound to the target DNA.


Figure 7. ELK-1 forms a multimolecular complex with SRF and the target DNA/(SRE-TFO)/SRF structure. ELK-1 and SRF were transcribed and translated in vitro. Equivalent amounts of the translation products were analysed by EMSA in the presence of the target DNA/(SRE-TFO) complex.

Formation of a multimolecular complex: target DNA/hairpin-TFO/transcription factors

The formation of a multimolecular complex including the target DNA, the hairpin-TFO, and transcription factors was demonstrated by EMSA. In these studies, an end-labelled ClaI-Ecl136I fragment (102 bp) from the pVPX1 plasmid which contains the target sequence was prepared. When this probe was incubated with the SRE-TFO or the mSRE-TFO, but not with the SRE-mTFO, a retarded band corresponding to the triplex structure could be observed (Fig. 6 A, lanes 2, 3, 6, 7). Addition of the SRF protein resulted in the appearance of a further retarded band migrating with a mobility similar to that of the SRE-TFO/SRF (Fig. 6 A, lane 3). It is not surprising that the mobility of the multimolecular complex (duplex DNA/hairpin-TFO/SRF) was similar to that of the hairpin-TFO/SRF complex; indeed, in EMSA the mobility of protein-DNA complexes is mainly dictated by the protein. The target DNA/hairpin TFO/SRF complex was not observed when one of the two functional sites of the bi-functional oligonucleotide was mutated, i.e., in the case of the SRE-mTFO or the mSRE-TFO (Fig. 6 A, lanes 1, 2). Furthermore, no complexes were observed in the absence of TFOs, indicating that the protein could not bind directly to the target DNA probe. Thus the appearance of the complex requires an interaction between the hairpin-TFO and both the target DNA and the transcription factors. The specificity of the interaction was further confirmed by competition experiments: an excess of unlabelled SRE resulted in a decrease in the intensity of the corresponding band (Fig. 6 B, lanes 1-3). In addition, after binding to the target DNA, the SRE-TFO retains its ability to form a ternary complex with SRF and ELK-1 proteins, as demonstrated by the `super-super shift' observed in the presence of ELK-1 (Fig. 7 ).

Current models for transcription activation (27 ,28 ) suggest that the recruitment of transcription factors to a gene promoter region plays a pivotal role in gene regulation. In addition, double hybrid experiments demonstrate that transactivation domains are independent of the DNA binding domains and seem to be functional whatever the way in which they are recruited to the promoter region. We suggest that hairpin-TFOs able to recruit transcription factors to the target DNA may prove useful in the design of new tools for artificial regulation of gene expression.

ACKNOWLEDGEMENTS

We thank Dr E. Lescot for oligonucleotide synthesis. We are very thankful to Drs D.Trouche and A.Debin for fruitful discussions.This work was supported by a SIDACTION research fellowship to F.S.

REFERENCES

1 Grigoriev, M., Praseuth, D., Guieysse, A. L., Robin, P., Thuong, N. T., Hélène, C., and Harel-Bellan, A. (1993) Proc. Natl. Acad. Sci. USA 90, 3501-3505. MEDLINE Abstract

2 Sun, J. S., Garestier, T., and Helene, C. (1996) Curr. Opin. Struct. Biol. 6, 327-333.

3 Frank-Kamenetskii, M. D., and Mirkin, S. M. (1995) Annu. Rev. Biochem. 64, 65-95.

4 Strobel, S. A., and Dervan, P. B. (1991) Nature 350, 172-174.

5 Strobel, S. A., Doucette-Stamm, L. A., Riba, L., Housman, D. E., and Dervan, P. B. (1991) Science 254, 1639-1642.

6 Giovannangeli, C., Diviacco, S., Labrousse, V., Gryaznov, S., Charneau, P., and Helene, C. (1997) Proc. Natl. Acad. Sci. USA 94, 79-84. MEDLINE Abstract

7 Maher, L. J. III. (1996) Cancer Invest. 14, 66-82.

8 Liberles, D. A., and Dervan, P. B. (1996) Proc. Natl. Acad. Sci. USA 93, 9510-9514.

9 Svinarchuk, F., Monnot, M., Merle, A., Malvy, C., and Fermandjian, S. (1995) Nucleic Acids Res. 23, 3831-3836. MEDLINE Abstract

10 Treisman, R. (1990) Semin. Cancer Biol. 1, 47-58. MEDLINE Abstract

11 Treisman, R. (1985) Cell 42, 889-902. MEDLINE Abstract

12 Treisman, R. (1986) Cell 46, 567-574. MEDLINE Abstract

13 Norman, C., Runswick, M., Pollock, R., and Treisman, R. (1988) Cell 55, 989-1003. MEDLINE Abstract

14 Shaw, P. E. (1992) EMBO J. 11, 3011-3019.

15 Phan-Dinh-Tuy, F., Tuil, D., Schweighoffer, F., Pinset, C., Kahn, A., and Minty, A. (1988) Eur. J. Biochem. 173, 507-515.

16 Schrster, H., Mueller, C. G., Meese, K., and Nordheim, A. (1990) EMBO J. 9, 1123-1130.

17 Shaw, P. E., Schrîter, H., and Nordheim, A. (1989) Cell 56, 563-572.

18 Magnaghi-Jaulin, L., Masutani, H., Robin, P., Lipinski, M., and Harel-Bellan, A. (1996) Nucleic Acids Res. 24, 1052-1058.

19 Trouche, D., Grigoriev, M., Lenormand, J. L., Robin, P., Leibovitch, S. A., Sassone-Corsi, P., and Harel-Bellan, A. (1993) Nature 363, 79-82. MEDLINE Abstract

20 Svinarchuk, F., Cherny, D., Debin, A., Delain, E., and Malvy, C. (1996) Nucleic Acids Res. 24, 3858-3865. MEDLINE Abstract

21 Dubochet, J., Ducommun, M., Zollinger, M., and Kellenberger, E. (1971) J. Ultrastruct. Res. 35, 147-167. MEDLINE Abstract

22 Delain, E., and Le Cam, E. (1995) In Morel, G. (ed), Visualisation of Nucleic Acids. CRC Press, Boca Raton, FL, USA, pp. 35-56.

23 Delain, E., Fourcade, A., Revet, B., and Mory, C. (1992) Microsc. Microanal. Microstruct. 3, 175-186.

24 Svinarchuk, F., Paoletti, J., and Malvy, C. (1995) J. Biol. Chem. 270, 14068-14071. MEDLINE Abstract

25 Voloshin, O. N., Mirkin, S. M., Lyamichev, V. I., Belotserkovskii, B. P., and Frank-Kamenetskii, M. D. (1988) Nature 333, 475-476.

26 Svinarchuk, F., Debin, A., Bertrand, J. R., and Malvy, C. (1996) Nucleic Acids Res. 24, 295-302. MEDLINE Abstract

27 Ptashne, M., and Gann, A. A. (1990) Nature 346, 329-331. MEDLINE Abstract

28 Nikolov, D. B., and Burley, S. K. (1997) Proc. Natl. Acad. Sci. USA 94, 15-22.

29 Svinarchuk, F., Bertrand, J. R., and Malvy, C. (1994) Nucleic Acids Res. 22, 3742-3747. MEDLINE Abstract


*To whom correspondence should be addressed at: Laboratoire de Biochimie-Enzymologie, PR-2, CNRS URA 147, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France. Tel: +33 1 42 1145 91; Fax: +33 1 42 1152 76; Email: fedorsvi@igr.fr
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Duca, P. Vekhoff, K. Oussedik, L. Halby, and P. B. Arimondo
The triple helix: 50 years later, the outcome
Nucleic Acids Res., September 1, 2008; 36(16): 5123 - 5138.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (311K) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Svinarchuk, F.
Right arrow Articles by Chern D$[corrected to Cherny, D]
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svinarchuk, F.
Right arrow Articles by Chern D$[corrected to Cherny, D]
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?